Accessibility Menu
Cann Group logo

Cann Group(ASX) CAN

Market CapA$4.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-99%
1 Year-77%
1 Month-25%
A$0.00
+0.00%
+0.00Today
Cann Group last closing stock price
MetricPriceDate
Last closeAUD 0.002026-08-13
Cann Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.002026-08-06
1 month-25%AUD 0.002026-07-14
3 month-40%AUD 0.012026-05-15
Year to date-66.67%AUD 0.012025-12-31
1 year-76.92%AUD 0.012025-08-13
3 year-97.6%AUD 0.132023-08-14
5 year-99.03%AUD 0.312021-08-13
Since inception-99.5%AUD 0.612017-05-04

Cann Group Financials at a Glance

Market Cap

A$4.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$26.81M

Net Income (TTM)

-A$32.87M

EPS (TTM)

A$0.01

P/E Ratio

0.26

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Price

A$0.00

Volume

306,065

Open

A$0.00

Previous Close

A$0.00

Daily Range

A$0.00 - A$0.00

52-Week Range

A$0.00 - A$0.02

Estimated Earnings Date

Aug 28, 2026

CAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cann Group

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.

Products and Services
  • Genetic development of cannabis strains for medicinal use
  • Cultivation and manufacturing of therapeutic cannabis products
  • Distribution of products for domestic and international markets
Growth Outlook
  • Recent revenue of AUD 4.5 million indicates potential for growth
  • Expansion into international markets enhances revenue opportunities
  • Focus on research and development may lead to innovative products
Financial Highlights
  • Net income of AUD 26.4 million reported in the latest quarter
  • Trailing twelve months (TTM) revenue of AUD 45.2 million shows upward trend
  • Current ratio of 0.42 suggests liquidity challenges
Cann Group Limited is positioned in the growing medicinal cannabis industry, with a focus on both domestic and international markets. The recent revenue figures reflect a positive trajectory, while the company's commitment to research and development may lead to innovative product offerings. However, liquidity challenges indicated by the current ratio warrant attention. Overall, Cann Group Limited presents an intriguing opportunity within the healthcare sector, particularly for those interested in the evolving landscape of medicinal cannabis.
AI Generated • Aug 1, 2026

Industry

Pharmaceuticals

CEO

Jennifer Lee Pilcher

Headquarters

Mildura, VIC 3501, AU

CAN Financials

Key Financial Metrics (TTM)

Gross Margin

-20.82%

Operating Margin

-97.39%

Net Income Margin

130.29%

Return on Equity

93.89%

Return on Capital

-12.24%

Return on Assets

26.52%

Earnings Yield

3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$4.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

306.06K

Avg. Volume

5.07M

Financials (TTM)

Gross Profit

-A$6.32M

Operating Income

-A$24.21M

EBITDA

-A$16.80M

Operating Cash Flow

-A$18.77M

Capital Expenditure

-A$442.00K

Free Cash Flow

-A$19.21M

Cash & ST Invst.

A$955.00K

Total Debt

A$15.10M

Cann Group Performance Analysis

Cann Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 6,411,000N/A
20232023-06-30AUD 13,777,000114.9%
20242024-06-30AUD 15,373,00011.6%
20252025-06-30AUD 11,300,000-26.5%
Cann Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-306.5%
Q22024-12-31-28.5%
Q42025-06-304.9%
Q22025-12-31-33.4%
Cann Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.07N/A
20232023-06-30AUD -0.0915.9%
20242024-06-30AUD -0.1131.4%
20252025-06-30AUD -0.04-62.5%
Cann Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-147.9%
Q22024-12-3173.5%
Q42025-06-309.4%
Q22025-12-31255.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$4.52M

-46.7%

Gross Profit

-A$4.46M

+51.8%

Gross Margin

-98.63%

N/A

Market Cap

A$4.98MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$124.55K

N/A

Employees

40

N/A

Net Income

A$26.38M

+284.0%

EBITDA

-A$2.49M

+61.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$955.00K

-41.6%

Total Debt

A$15.10M

-76.8%

Accounts Receivable

A$868.00K

-74.0%

Inventory

A$6.48M

-47.7%

Long Term Debt

A$157.00K

N/A

Short Term Debt

A$14.95M

-77.1%

Return on Assets

26.52%

N/A

Return on Invested Capital

-31.90%

N/A

Free Cash Flow

-A$115.00K

+98.6%

Operating Cash Flow

-A$11.00K

+99.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PER.AXPercheron Therapeutics Limited
A$0.01+11.11%
IVX.AXInvion Limited
A$0.04+2.56%
HIQ.AXHITIQ Limited
A$0.01+0.00%
BGT.AXBio-Gene Technology Limited
A$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About CAN

What is the current price of Cann Group?

Cann Group is trading at A$0.00 per share.

What is the 52-week range for Cann Group?

Over the past 52 weeks, Cann Group has traded between A$0.00 and A$0.02.

How much debt does Cann Group have?

As of the most recent reporting period, Cann Group reported total debt of A$76.18M.

How much cash does Cann Group have on hand?

Cann Group reported A$10.00K in cash and cash equivalents in its most recent financial results.

What is Cann Group’s dividend yield?

Cann Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.